Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Intelligent Ultrasound Group Plc ( (GB:IUG) ) just unveiled an announcement.
Intelligent Ultrasound Group Plc has announced the court sanction of its acquisition by Surgical Science Sweden AB, which will be executed through a court-sanctioned scheme of arrangement. With all conditions satisfied except the delivery of the court order to the Registrar of Companies, the acquisition is expected to become effective on 18 February 2025. In preparation, Intelligent Ultrasound has allotted new ordinary shares, which will commence trading on AIM on 17 February 2025, while trading of existing shares will be suspended on 18 February 2025. This acquisition marks a significant strategic move for Intelligent Ultrasound, potentially enhancing its market position and offering increased value to stakeholders.
More about Intelligent Ultrasound Group Plc
Intelligent Ultrasound Group Plc is a leading company in the ultrasound simulation and education industry, specializing in real-time high-fidelity virtual reality simulation for ultrasound training. Their primary products include the ScanTrainer obstetrics and gynaecology simulator, HeartWorks echocardiography simulator, BodyWorks Eve Point of Care and Emergency Medicine simulator, BabyWorks Neonate and Paediatric simulator, and NeedleTrainer for ultrasound-guided needling. The company has sold over 1,800 simulators to more than 800 medical institutions worldwide.
YTD Price Performance: 0.98%
Average Trading Volume: 256,054
Technical Sentiment Consensus Rating: Sell
Current Market Cap: £42.62M
For detailed information about IUG stock, go to TipRanks’ Stock Analysis page.
